Cresanto Global Limited (BOM:531207)
4.650
+0.220 (4.97%)
At close: Apr 20, 2026
Cresanto Global Revenue
In the fiscal year ending March 31, 2026, Cresanto Global had annual revenue of 756.00K INR, down -85.62%. Cresanto Global had revenue of 17.00K in the quarter ending March 31, 2026, a decrease of -99.67%.
Revenue
756.00K
Revenue Growth
-85.62%
P/S Ratio
26.29
Revenue / Employee
151.20K
Employees
5
Market Cap
19.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 756.00K | -4.50M | -85.62% |
| Mar 31, 2025 | 5.26M | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 206.32K | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 1.16B |
| Fabino Enterprises | 208.41M |
| Beryl Drugs | 188.20M |
| Brawn Biotech | 169.78M |
| Unjha Formulations | 157.49M |
| Decipher Labs | 142.75M |
| Ganga Pharmaceuticals | 28.28M |
| Emmessar Biotech & Nutrition | 24.07M |